Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor

CompletedOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

June 17, 2020

Study Completion Date

June 17, 2020

Conditions
Testicular Germ Cell Tumor
Interventions
OTHER

EORTC QLQ-CIPN20

EORTC QLQ-CIPN20 is a 20-item chemotherapy-induced peripheral neuropathy-specific questionnaire which includes three scales assessing sensory (9 items: #31-36, 39, 40, 48), motor (8 items: #37, 38, 41-45, 49), and autonomic (3 items: #46, 47, 50) symptoms and functioning with each item measured on a 1-4 scale (1 - not at all; 4 - very much).

Trial Locations (3)

46202

Indiana University Health Hospital, Indianapolis

Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis

55905

Mayo Clinic Department of Medical Oncology, Rochester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mayo Clinic

OTHER

lead

Costantine Albany

OTHER